Supplementary Figure S2 from IL4/IL13 Inhibition via Dupilumab Reduces Malignant T-cell Proliferation and Promotes Antitumor Immunity in Sézary Syndrome
Abstract
Figure S2: 0 tSNE-1-50 25-25 0 tSNE-1-50 25-25-25 0 tSNE-1-50 25 0-25-25 0 tSNE-1-50 25-25 0 tSNE-1 25 Grouping of SS and normal blood populations.
Fields of Study & Subjects
Cutaneous lymphoproliferative disorders research
Dermatology and Skin Diseases
Psoriasis: Treatment and Pathogenesis
Publication details
- Publication date
- 3 February 2026